Evidence map›Paper›PMID 33743067›Full record

ArticleHistochemistry and cell biology2021

Dimethyl sulfoxide acutely enhances regulated insulin secretion in the MIN6-K8 mouse insulinoma cell line.

Christopher M Carmean, Lidan Zhao, Michael Landeche, Bijoy Chellan, Robert M Sargis

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Histochemistry and cell biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Experimental Approaches to Diabetes Mellitus.The Eurasian journal of medicine · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Christopher M CarmeanDivision of Endocrinology, Diabetes, and Metabolism; Department of Medicine, College of Medicine, University of Illinois at Chicago, 835 S. Wolcott, Suite E625, M/C 640, Chicago, IL, 60612, USA. christopher.carmean@gmail.com.ORCID http://orcid.org/0000-0001-7662-9946
Lidan ZhaoDivision of Endocrinology, Diabetes, and Metabolism; Department of Medicine, College of Medicine, University of Illinois at Chicago, 835 S. Wolcott, Suite E625, M/C 640, Chicago, IL, 60612, USA.
Michael LandecheDivision of Endocrinology, Diabetes, and Metabolism; Department of Medicine, College of Medicine, University of Illinois at Chicago, 835 S. Wolcott, Suite E625, M/C 640, Chicago, IL, 60612, USA.
Bijoy ChellanDivision of Endocrinology, Diabetes, and Metabolism; Department of Medicine, College of Medicine, University of Illinois at Chicago, 835 S. Wolcott, Suite E625, M/C 640, Chicago, IL, 60612, USA.
Robert M SargisDivision of Endocrinology, Diabetes, and Metabolism; Department of Medicine, College of Medicine, University of Illinois at Chicago, 835 S. Wolcott, Suite E625, M/C 640, Chicago, IL, 60612, USA.
Diabetes Australia · AUUniversity of Illinois Chicago · US

Funding

Pilot and Feasibility ProgramP30DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI Raghavendra G Mirmira · 2013 to 2026
$20.9M
Pilot Program CoreP30ES027792 · NIEHS · UNIVERSITY OF CHICAGO · PI Gokhan M. Mutlu, Gail S Prins · 2017 to 2026
$13.6M
Selenoproteins in Arsenic-Induced Metabolic DysfunctionR01ES028879 · NIEHS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SARGIS, ROBERT M · 2018 to 2022
$2.7M
NIDDK NIH HHS P30 DK020595NIEHS NIH HHS P30 ES027792NIEHS NIH HHS R01 ES028879NIH HHS P30-DK-020595NIH HHS P30-ES-027792NIH HHS R01-ES-028879
6 · The paper itself

Abstract

Diabetes mellitus is a metabolic disorder projected to afflict 700 million people globally by 2045. Fundamental to the progression of diabetes is an insufficient supply of insulin to meet metabolic demand. The MIN6-K8 cell line is a mouse insulinoma model of pancreatic β-cells frequently used to study the mechanisms of insulin secretion. Here, we evaluated the effects of short-term exposure to dimethyl sulfoxide (DMSO), a polar aprotic solvent commonly used in drug screening, on physiological characteristics of MIN6-K8 cells. Short-term exposure of MIN6-K8 cells to DMSO enhanced glucose-induced and tolbutamide-stimulated insulin secretion without significant effects on basal secretion or potassium responsiveness. Calcium influx was enhanced during glucose and tolbutamide treatments, suggesting that DMSO's mechanism of action is upstream of calcium-dependent insulin granule exocytosis. Based on these studies, investigators should use caution when conducting experiments with DMSO in the MIN6-K8 cell line and should report all DMSO concentrations when used as a solvent.

Indexed as

AnimalsCells, CulturedDimethyl SulfoxideInsulinInsulinomaMiceDimethyl SulfoxideInsulinDiabetesDimethyl sulfoxideDrug discoveryDrug screeningGlucoseInsulin secretion

Identifiers

PMID33743067
PMCPMC8277720
OpenAlexW3137657004

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.